First human test of new drug for debilitating muscle disease in children
NCT ID NCT07282652
Summary
This is a very early study to see if a new drug called RAG-18 is safe for children with Duchenne muscular dystrophy (DMD). It will involve about 12 boys aged 4-15, giving them increasing doses to check for side effects. The study will also measure how the drug moves through the body and look for early signs it might help muscle function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY (DMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College Hospital
Beijing, 100730, China
Conditions
Explore the condition pages connected to this study.